Terminated NA INTERVENTIONAL 4-arm NCT01996111

Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis (dHACM)

A Prospective, Randomized, Controlled, Blinded, Comparative Study of Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis

Sponsor: MiMedx Group, Inc.

Conditions Plantar Fasciitis

Interventions Injection of 1.0 cc of 0.9% Saline Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension Injection of 1.0 cc of 40 mg/ml micrograft dHACM suspension

Updated 5 times since 2017 Last updated: Jun 12, 2014 Started: Sep 30, 2013 Primary completion: Mar 31, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Change in Regulatory Status

Other terminated trials from MiMedx Group, Inc.

More terminations from MiMedx Group, Inc.

A NA clinical study on Plantar Fasciitis, this trial is terminated or withdrawn. The trial is conducted by MiMedx Group, Inc. and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MiMedx Group, Inc.

Data source: MiMedx Group, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Roanoke, United States